Genea Biocells

Human Stem Cell Model of Muscular Dystrophy (FSHD) – qPCR

Skeletal Muscle Differentiation Media

Genea Biocells provides the world’s first commercially available media system to differentiate human pluripotent stem cells into skeletal muscle:

Achieves typically >50% MF20-positive myotubes

  • Simple 3-step process involves only media changes and cell passaging
  • No cell sorting steps required
  • No transfection of myogenic transcription factors
  • Tested on a wide range of human embryonic & induced pluripotent stem cell lines

Kit Components:

  • 250 ml Skeletal Muscle Induction medium
  • 250 ml Myoblast medium
  • 250 ml Myotube medium

Ordering information

Researchers at not-for-profit organizations and may order directly by filling out the contact form or through one of our distributors. For-profit-organizations should contact us about licensing and supply agreement options.

Leave a Reply

Your email address will not be published. Required fields are marked *